Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: honest (34)

Tisacel-Bendamustine(90)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY DLBCL/ FL – TISACEL – BENDAMUSTINE (90) Regimen This regim
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Tisacel-Bendamustine90.pdf

Bendamustine-Obinutuzumab

Description: Chemotherapy Protocol Non-Hodgkin Lymphoma Bendamustine-Obinutuzumab Regimen • NHL – Bendamustine-Obinutuzumab Indication • Obinut
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Obinutuzumab.pdf

Bendamustine_90_Rituximab

Description: Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (90)-RITUXIMAB There are multiple versions of this protocol in u
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-90-Rituximab.pdf

Bendamustine_70_Rituximab

Description: Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (70)-RITUXIMAB There are multiple versions of this protocol in u
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-70-Rituximab.pdf

DA_3+10

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (3+10)–Cytarabine-Daunorubicin In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-DA (3+10
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-3-10.pdf

Clinical candour: The absence of spin

Description: Auto Generated Title On these pages I discuss the clinical law on which our nursing and medical staff rely when caring
Url: /HealthProfessionals/Clinical-law-updates/Clinical-candour-The-absence-of-spin.aspx

41 to 46 of 46

Previous 1 2 3 4 5 Next